GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
– Awarded $4.7 Million Government Grant Funding to support the building of a high-tech manufacturing facility…
– Awarded $4.7 Million Government Grant Funding to support the building of a high-tech manufacturing facility…
SAN DIEGO, Aug. 11, 2021 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical…
Management will Host a Conference Call Today at 4:30 p.m. (ET) to Review Financial Results…
– Dosed First Patient in Phase 1/2 Clinical Trial of CFT7455, a novel IKZF1/3 Degrader,…
Fast-Track Designation Granted by FDA in ROS1-Positive Advanced Non-Small Cell Lung Cancer Patients Pretreated With…
MALVERN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a…
Announced Multi-Target Drug Discovery Collaboration with Zentalis Pharmaceuticals in Oncology— Granted Two Patents for Compounds…
WATERTOWN, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
– Initiated Phase 2 study of PRA023 and its companion diagnostic in Ulcerative Colitis (UC)…
Company Shows Continued Progress Demonstrating Differentiation of RAS(ON) Inhibitors, Targeting Additional RAS Variants and Progressing…
Long-time Washington Insider is Uniquely Positioned at the Intersection of Law, Politics, Business, and Finance…
SANTA MONICA, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or…
Saint-Herblain (France), August 11th, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
OSLO, Norway, Aug. 11, 2021 (GLOBE NEWSWIRE) — Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical…
August 11, 2021; Copenhagen, Denmark; Interim Report for the First Half of 2021 Highlights The…
Oslo, 11 August 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune…
First-in-human study evaluating recombinant hyperimmunes SOUTH SAN FRANCISCO, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) —…
AUSTIN, Texas, Aug. 11, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
VANCOUVER, British Columbia, Aug. 11, 2021 (GLOBE NEWSWIRE) — In a recent announcement Life Sciences…
– Second human trial to be conducted as part of a long-term Master Service Agreement…